Velan Capital Investment Management’s Collegium Pharmaceutical COLL Stock Holding History

Velan Capital Investment Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-28,685	Closed	-$822K	–	50
2024 Q4	$822K	Buy	+28,685	New	+$949K	0.71%	17
2023 Q2	–	Sell	-22,095	Closed	-$530K	–	33
2023 Q1	$530K	Sell	22,095 -22,353	-50%	-$593K	0.45%	26
2022 Q4	$1.03M	Buy	44,448 +4,491	+11%	+$90.6K	0.91%	20
2022 Q3	$640K	Buy	+39,957	New	+$705K	0.63%	20

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Velan Capital Investment Management's COLL Position: Q1 2025 in Review

Velan Capital Investment Management sold out of Collegium Pharmaceutical (COLL) in Q1 2025, closing a stake of 28,685 shares — an estimated $822K sold.

Velan Capital Investment Management first reported a position in COLL in Q3 2022 and held it in 4 quarters. The position peaked at $1.03M in Q4 2022. 242 funds tracked by Wall St. Rank hold COLL as of Q1 2025.

Velan Capital Investment Management reported no remaining Collegium Pharmaceutical position as of Q1 2025 after selling out during the quarter.
Velan Capital Investment Management sold 28,685 Collegium Pharmaceutical shares in Q1 2025, an estimated $822K.
Velan Capital Investment Management first reported a position in Collegium Pharmaceutical in Q3 2022 and held it in 4 quarters.
Velan Capital Investment Management's Collegium Pharmaceutical position peaked at $1.03M in Q4 2022.
242 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2025.

Based on Velan Capital Investment Management's 13F filing for Q1 2025, filed 15 May 2025.